Medtronic Ave Inc., Medtronic Vascular, Inc., A/K/A Medtronic Vascular, Inc. v. Cordis Corporation

367 F.3d 147, 100 F. App'x 865, 100 Fed. Appx. 865, 2004 U.S. App. LEXIS 8533, 2004 WL 916355
CourtCourt of Appeals for the Third Circuit
DecidedApril 30, 2004
Docket04-1042
StatusPublished
Cited by10 cases

This text of 367 F.3d 147 (Medtronic Ave Inc., Medtronic Vascular, Inc., A/K/A Medtronic Vascular, Inc. v. Cordis Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medtronic Ave Inc., Medtronic Vascular, Inc., A/K/A Medtronic Vascular, Inc. v. Cordis Corporation, 367 F.3d 147, 100 F. App'x 865, 100 Fed. Appx. 865, 2004 U.S. App. LEXIS 8533, 2004 WL 916355 (3d Cir. 2004).

Opinions

BECKER, Circuit Judge.

This appeal by Cordis Corp. (“Cordis”), the defendant in a patent infringement lawsuit brought against it by Medtronic AVE, Inc. (“Medtronic AVE”), requires us to decide whether Cordis’s claim that it has a license to use certain patents should be determined by an arbitrator. The District Court held that the dispute was not arbitrable, and enjoined arbitration. We will vacate and remand. Because the parties are fully familiar with the background facts and procedural history we need not set them forth, and limit our discussion to our ratio decidendi.1

I.

Medtronic AVE’s suit alleges that Cor-dis is infringing certain patents (the “Boneau patents”) in the field of coronary stents. Cordis asserts as one of its defenses that it has a license to use the patents under a Settlement and License Agreement (the “Agreement”) that it entered into with the parent corporation of Medtronic AVE to settle prior litigation.2 At the District Court, Cordis sought to stay the proceedings in the infringement suit and compel arbitration on the issue of its license defense. Medtronic AVE opposed. The District Court first held that the dispute was arbitrable, but then on reconsideration held that it was not. The District Court entered an order enjoining arbitration, and denied Cordis’s motion to stay its proceedings. Cordis appeals to this Court under 9 U.S.C. § 16(a)(1)(A), which provides for interlocutory review of an order “refusing a stay of any action” pending arbitration.

The contract dispute at issue is governed by state law (New York law, under § 11.04 of the Agreement), though we are also guided by cases decided under the Federal Arbitration Act, codified as amended at 9 U.S.C. §§ 1-16. These cases, which lay down the overarching principles by which arbitration clauses are interpreted, are Moses H. Cone Memorial Hospital v. Mercury Construction Corp., 460 U.S. 1, 24, 103 S.Ct. 927, 74 L.Ed.2d 765 (1983) (explaining that there is a “liberal federal policy favoring arbitration”); AT & T Technologies, Inc. v. Communications Workers of America, 475 U.S. 643, 650, 106 S.Ct. 1415, 89 L.Ed.2d 648 (1986) (“ ‘[An] order to arbitrate ... should not be denied unless it may be said with positive assurance that the arbitration clause is not susceptible of an interpretation that covers the asserted dispute.’ ” (quoting United Steelworkers of Am. v. Warrior & Gulf Navigation Co., 363 U.S. 574, 582-83, 80 S.Ct. 1347, 4 L.Ed.2d 1409 (1960))); [867]*867First Options of Chicago, Inc. v. Kaplan, 514 U.S. 938, 943, 115 S.Ct. 1920, 131 L.Ed.2d 985 (1995) (“[Arbitration is simply a matter of contract between the parties; it is a way to resolve those disputes-but only those disputes-that the parties have agreed to submit to arbitration.”); and Suter v. Munich Reinsurance Co., 223 F.3d 150, 155 (3d Cir.2000) (“ ‘Any doubts concerning the scope of arbitrable issues should be resolved in favor of arbitration.’ ” (quoting Patten Sec. Corp. v. Diamond Greyhound & Genetics, Inc., 819 F.2d 400, 405-07 (3d Cir.1987))).

II.

These are useful guidelines, and they are all easily satisfied in this case because we conclude that the contract clearly makes this dispute arbitrable. Two provisions from the agreement command our attention. First is language from Article V, which is captioned “Resolution of Patent Disputes”:

In addition [to other provisions specific to certain enumerated patents], any dispute, claim, or controversy arising under this Agreement which relates to patent matters, the resolution of which is not specifically provided for [in another part of the Agreement], shall be resolved pursuant to binding arbitration....

Agreement § 5.02. Second is language from Article X, which is captioned “Alternative Dispute Resolution”:

Any dispute, claim, or controversy (“disputes”) arising from or relating to this Agreement or alleged breaches thereof (excluding all disputes related to patent matters, such as all disputes related in whole or in part to a Licensed Patent or any patent alleged to be a Licensed Patent or related to whether a product is in the Field, which disputes shall be resolved pursuant to Article V) ... shall be resolved by binding Alternative Dispute Resolution....

Agreement § 10.01. Article X and Article V provide (in sections we have not reproduced) somewhat different procedures for dispute resolution.

We agree with Cordis that Article X establishes a seamless division of “disputéis], claim[s], [and] controversies]” into two classes: Those that are arbitrable under Article X and those that are arbitrable under Article V, the latter being “disputes related to patent matters.” So long as a dispute “aris[es] from or relatfes] to” the Agreement, it must be arbitrated under either Article Y or Article X. There is simply no basis in the plain language of the Agreement for Medtronic AVE’s contention that there is an unspoken third category of disputes (to which putative class the instant dispute would belong) that is not governed by either Article V or Article X. This is not “Seylla and Charybdis” where one may pass in the narrow channel between; rather, in the Agreement, “all roads lead to Rome,” for the license issue is either subject to Article V, or if it is not subject to Article V, then it is necessarily subject to Article X.

These conclusions, of course, depend upon the accuracy of the proposition that the dispute in question “aris[es] from or relat[es] to” the Agreement. The District Court held on reconsideration that, this being a licensing agreement, only disputes about licensed patents would “aris[e] from or relat[e] to” the Agreement. Since the Court concluded that the Boneau patents were not licensed under the Agreement (and hence not covered by the Agreement), it held that this dispute did not arise from the Agreement, and hence was not arbitrable. Medtronic AYE endorses this reasoning on appeal. We disagree.

Prehminarily, we note the longstanding rule that courts “have no business weigh[868]*868ing the merits” of the issue proposed to be arbitrated. United Steelworkers of Am. v. Am. Mfg. Co., 363 U.S. 564, 568, 80 S.Ct. 1343 (1960). This was, as the District Court recognized, the effect of its ruling on reconsideration. This alone does not render the District Court’s analysis incorrect, for there may be cases in which a preliminary ruling on the merits is unavoidable.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Monfared v. St. Luke's University Health Network
182 F. Supp. 3d 188 (E.D. Pennsylvania, 2016)
United States ex rel. Hagerty v. Cyberonics, Inc.
146 F. Supp. 3d 337 (D. Massachusetts, 2015)
Epix v. MARSH & McLENNAN COMPANIES
982 A.2d 1194 (New Jersey Superior Court App Division, 2009)
Angrisani v. Financial Technology Ventures
952 A.2d 1140 (New Jersey Superior Court App Division, 2008)
Port Erie Plastics, Inc. v. Uptown Nails, LLC
350 F. Supp. 2d 659 (W.D. Pennsylvania, 2004)
Miron v. BDO Seidman, LLP
342 F. Supp. 2d 324 (E.D. Pennsylvania, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
367 F.3d 147, 100 F. App'x 865, 100 Fed. Appx. 865, 2004 U.S. App. LEXIS 8533, 2004 WL 916355, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medtronic-ave-inc-medtronic-vascular-inc-aka-medtronic-vascular-ca3-2004.